Despite progress in antiplatelet, anticoagulant therapy and invasive strategy, patients with non-ST-segment elevation acute coronary syndrome present an elevated risk of events. There is no consensus on the use of a single anticoagulant which can be administered in the Coronary Unit and also at the time of coronary intervention. The anticoagulant direct factor Xa inhibitor,...
80% of the global burden of cardiovascular disease is located in countries with low or middle incomes. The aim of this study was to demonstrate the contrast in risk factors for cardiovascular disease incidence and mortality in low, medium and high income countries. This study included 155245 patients from 628 cities in 17 countries over...
This double-blind, multicenter randomized study compared aliskiren versus placebo in 613 patients with coronary artery disease and systolic blood pressure between 125 and 139 mm Hg (pre hypertensive stage) together with 2 risk factors. All patients underwent coronary intravascular ultrasonography (IVUS) and randomized to aliskiren 300 mg (305 patients) or placebo (308 patients). At 72...
On April 12, a five year cooperation agreement was signed in Sao Paulo (Brazil) between SOLACI and CRF/TCT. The agreement was signed by SOLACI President, Dr. Oscar Mendiz, SOLACI Vicepresident, Dr. Jamil Abdala Saad, and CRF/TCT Excecutive Director, Mr. Johnnie White. The agreement defines several areas of cooperation. Among others, an annual meeting “SOLACI in...
The Latin American Society of Interventional Cardiology (SOLACI) regrets to inform the deceased of Miguel Granja MD, renowned and prestigious pediatric interventional cardiologist. Dr. Granja was instructor of many physicians, both Argentinian and Latin American, which today practice pediatric interventionism and adult congenital heart disease. He was chief and creator of the Hemodynamics Service at...
The Latin American Society of Interventional Cardiology successfully relaunched its SOLidario program, practicing the implantation of an aortic valve catheter (TAVI) in the Instituto de Angiografía de Occidente at Cali. It was during the XXIV SOLACI Conference edition held on October 30 and 31 in Colombia. SOLACI understands the need to develop a social...
SOLACI thanks the Costantino Costantini Foundation of Curitiba City, Brazil and its director Dr. Costantino Costantini, for the invitation to participate in the 14th International Symposium of Interventional Cardiology, -Cardio Interv- held in that city from November 27 to 29, 2014. Leading international and Latin American guests attended the event. The program of high scientific...
This partnership brings some of the best SCAI has to offer to SOLACI members, with greater access to the top research published in CCI, even greater support for Fellows-in-training in Latin America, and provides for an even greater exchange of ideas and engagement between interventional leaders in Latin America with those from around the globe...
On April 12, a five year cooperation agreement was signed in Sao Paulo (Brazil) between SOLACI and CRF/TCT. The agreement was signed by SOLACI President, Dr. Oscar Mendiz, SOLACI Vicepresident, Dr. Jamil Abdala Saad, and CRF/TCT Excecutive Director, Mr. Johnnie White. The agreement defines several areas of cooperation. Among others, an annual meeting “SOLACI in...
Minimally invasive interventions allow us to respond to any complications related to the heart, so it is expected to decrease open-heart surgery dramatically; in a decade, minimally invasive procedures definitely replace conventional surgery. This was highlighted on Wednesday during the XXV Meeting of the Cardiac Catheterization and Interventional Cardiology of the Spanish Society of Cardiology...